Novartis (NVS)

Add to Watchlists
Create an Alert
103.83 +0.08  +0.08% NYSE Aug 3, 13:14 Delayed 2m USD

Novartis Price to Book Value:

3.184 for Aug. 3, 2015

View 4,000+ financial data types

Browse...
View Full Chart

Novartis Price to Book Value Chart

Export Data
Save Image

Novartis Historical Price to Book Value Data

View and export this data going back to 1996. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Aug. 3, 2015 3.184
July 31, 2015 3.181
July 30, 2015 3.164
July 29, 2015 3.180
July 28, 2015 3.152
July 27, 2015 3.114
July 24, 2015 3.122
July 23, 2015 3.160
July 22, 2015 3.106
July 21, 2015 3.180
July 20, 2015 3.254
July 17, 2015 3.244
July 16, 2015 3.245
July 15, 2015 3.197
July 14, 2015 3.248
July 13, 2015 3.192
July 10, 2015 3.165
July 9, 2015 3.067
July 8, 2015 3.037
July 7, 2015 3.041
July 6, 2015 3.024
July 2, 2015 3.060
July 1, 2015 3.021
June 30, 2015 3.016
June 29, 2015 3.122
June 26, 2015 3.166
   
June 25, 2015 3.195
June 24, 2015 3.221
June 23, 2015 3.257
June 22, 2015 3.236
June 19, 2015 3.175
June 18, 2015 3.218
June 17, 2015 3.204
June 16, 2015 3.207
June 15, 2015 3.172
June 12, 2015 3.227
June 11, 2015 3.256
June 10, 2015 3.252
June 9, 2015 3.186
June 8, 2015 3.215
June 5, 2015 3.215
June 4, 2015 3.266
June 3, 2015 3.286
June 2, 2015 3.262
June 1, 2015 3.273
May 29, 2015 3.255
May 28, 2015 3.304
May 27, 2015 3.281
May 26, 2015 3.226
May 22, 2015 3.291
May 21, 2015 3.321

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

NVS Price to Book Value Benchmarks

Companies
AstraZeneca 4.673
Bristol-Myers Squibb 7.238
GlaxoSmithKline 8.802

NVS Price to Book Value Range, Past 5 Years

Minimum 1.847 Nov 30 2010
Maximum 3.491 Feb 23 2015
Average 2.525

NVS Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("NVS", "price_to_book_value")
  • Last 5 data points: =YCS("NVS", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.